Rheumatoid arthritis trials in Portugal
6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Carnaxide, Vila Franca de Xira, Vila Nova de Gaia
- Age
- 18 years to 75 years
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - Phase 4Taking people3TR-PARTNER-RA
- Where
- Lisbon
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2024-511470-79-00 · EU 2024-511470-79-00 - Phase 4Taking peopleThe 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
- Where
- Lisbon
- Age
- 18 years and over
- People
- 197 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2022-502021-18-00 · EU 2022-502021-18-00 - Phase 2Taking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Lisbon, Vila Nova de Gaia
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - No phaseTaking peopleBiomarkers in Inflammatory Rheumatic Diseases Diagnosis
- Where
- Lisbon
- Age
- 18 years to 65 years
- People
- 134
- Run by
- Universidade Nova de Lisboa
See details and how to joinNCT06778343 - No phaseTaking peopleThe Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)
- Where
- Lisbon
- Age
- 18 years and over
- People
- 100
- Run by
- Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
See details and how to joinNCT06758817